Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study) (vol 13, pg 1, 2021)

被引：3
|
作者：
Rebuzzi, S. E.
Signori, A.
Banna, G.
机构：
来源：
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY | 2021年 / 13卷
关键词：
D O I：
10.1177/17588359211036552
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 31 条
  • [1] Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study)
    Rebuzzi, Sara Elena
    Signori, Alessio
    Banna, Giuseppe Luigi
    Maruzzo, Marco
    De Giorgi, Ugo
    Pedrazzoli, Paolo
    Sbrana, Andrea
    Zucali, Paolo Andrea
    Masini, Cristina
    Naglieri, Emanuele
    Procopio, Giuseppe
    Merler, Sara
    Tomasello, Laura
    Fratino, Lucia
    Baldessari, Cinzia
    Ricotta, Riccardo
    Panni, Stefano
    Mollica, Veronica
    Soraru, Maria
    Santoni, Matteo
    Cortellini, Alessio
    Prati, Veronica
    Soto Parra, Hector Jose
    Stellato, Marco
    Atzori, Francesco
    Pignata, Sandro
    Messina, Carlo
    Messina, Marco
    Morelli, Franco
    Prati, Giuseppe
    Nole, Franco
    Vignani, Francesca
    Cavo, Alessia
    Roviello, Giandomenico
    Pierantoni, Francesco
    Casadei, Chiara
    Bersanelli, Melissa
    Chiellino, Silvia
    Paolieri, Federico
    Perrino, Matteo
    Brunelli, Matteo
    Iacovelli, Roberto
    Porta, Camillo
    Buti, Sebastiano
    Fornarini, Giuseppe
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [2] The prognostic role of nephrectomy in patients (pts) with metastatic renal cell carcinoma (mRCC) treated with immunotherapy according to the novel prognostic Meet-URO score: Subanalysis of the Meet-URO 15 study.
    Rebuzzi, Sara Elena
    Signori, Alessio
    Banna, Giuseppe Luigi L.
    Buti, Sebastiano
    Rescigno, Pasquale
    Gemelli, Maria
    Panni, Stefano
    Massari, Francesco
    Soraru, Mariella
    Santoni, Matteo
    Cortellini, Alessio
    Prati, Veronica
    Parra, Hector Jose Soto
    Atzori, Francesco
    Di Napoli, Marilena
    Caffo, Orazio
    Messina, Marco
    Morelli, Franco
    Prati, Giuseppe
    Fornarini, Giuseppe
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [3] The prognostic value of peripheral blood inflammatory indices early variation in patients (pts) with metastatic renal cell carcinoma (mRCC) treated with nivolumab (Δ-Meet-URO analysis).
    Rebuzzi, Sara Elena
    Signori, Alessio
    Buti, Sebastiano
    Banna, Giuseppe Luigi L.
    Stellato, Marco
    Santini, Daniele
    Basso, Umberto
    De Giorgi, Ugo
    Chiellino, Silvia
    Salfi, Alessia
    Zucali, Paolo Andrea
    Masini, Cristina
    Naglieri, Emanuele
    Procopio, Giuseppe
    Milella, Michele
    Boccardo, Francesco
    Fratino, Lucia
    Pipitone, Stefania
    Porta, Camillo
    Fornarini, Giuseppe
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [4] The prognostic value of baseline and early variations of peripheral blood inflammatory ratios and their cellular components in patients with metastatic renal cell carcinoma treated with nivolumab: The Δ-Meet-URO analysis
    Rebuzzi, Sara Elena
    Signori, Alessio
    Stellato, Marco
    Santini, Daniele
    Maruzzo, Marco
    De Giorgi, Ugo
    Pedrazzoli, Paolo
    Galli, Luca
    Zucali, Paolo Andrea
    Fantinel, Emanuela
    Carella, Claudia
    Procopio, Giuseppe
    Milella, Michele
    Boccardo, Francesco
    Fratino, Lucia
    Sabbatini, Roberto
    Ricotta, Riccardo
    Panni, Stefano
    Massari, Francesco
    Soraru, Mariella
    Santoni, Matteo
    Cortellini, Alessio
    Prati, Veronica
    Soto Parra, Hector Jose
    Atzori, Francesco
    Di Napoli, Marilena
    Caffo, Orazio
    Messina, Marco
    Morelli, Franco
    Prati, Giuseppe
    Nole, Franco
    Vignani, Francesca
    Cavo, Alessia
    Roviello, Giandomenico
    Llaja Obispo, Miguel Angel
    Porta, Camillo
    Buti, Sebastiano
    Fornarini, Giuseppe
    Banna, Giuseppe Luigi
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [5] Prognostic Stratification by the Meet-URO Score in Real-World Older Patients With Metastatic Renal Cell Carcinoma (mRCC) Receiving Cabozantinib: A Subanalysis of the Prospective ZEBRA Study (Meet-URO 9)
    Damassi, Alessandra
    Cremante, Malvina
    Signori, Alessio
    Rebuzzi, Sara Elena
    Fornarini, Giuseppe
    Giudice, Giulia Claire
    Maruzzo, Marco
    Procopio, Giuseppe
    Soraru, Mariella
    Di Napoli, Marilena
    Fratino, Lucia
    Santini, Daniele
    Grillone, Francesco
    Ballestrin, Melissa
    Dionese, Michele
    Nasso, Cecilia
    Catalano, Fabio
    Murianni, Veronica
    Rescigno, Pasquale
    Anpalakhan, Shobana
    Banna, Giuseppe Luigi
    Basso, Umberto
    Buti, Sebastiano
    CLINICAL GENITOURINARY CANCER, 2024, 22 (02) : 126 - 133.e2
  • [6] Application of the Meet-URO score to metastatic renal cell carcinoma patients treated with second- and third-line cabozantinib
    Rebuzzi, Sara Elena
    Cerbone, Luigi
    Signori, Alessio
    Santoni, Matteo
    Murianni, Veronica
    De Giorgi, Ugo
    Procopio, Giuseppe
    Porta, Camillo
    Milella, Michele
    Basso, Umberto
    Massari, Francesco
    Maruzzo, Marco
    Iacovelli, Roberto
    Battelli, Nicola
    Carmisciano, Luca
    Banna, Giuseppe Luigi
    Buti, Sebastiano
    Fornarini, Giuseppe
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [7] Prognostic Impact of IMDC Category Shift From Baseline to Nivolumab Initiation in Metastatic Renal Cell Carcinoma: A Sub-Analysis of the MEET-URO 15 Study
    Maiorano, Brigida Anna
    Catalano, Martina
    Mercinelli, Chiara
    Roviello, Giandomenico
    Maruzzo, Marco
    De Giorgi, Ugo
    Chiellino, Silvia
    Sbrana, Andrea
    Galli, Luca
    Zucali, Paolo Andrea
    Masini, Cristina
    Naglieri, Emanuele
    Procopio, Giuseppe
    Merler, Sara
    Fratino, Lucia
    Baldessari, Cinzia
    Ricotta, Riccardo
    Mollica, Veronica
    Soraru, Mariella
    Tudini, Marianna
    Prati, Veronica
    Malgeri, Andrea
    Atzori, Francesco
    Di Napoli, Marilena
    Caffo, Orazio
    Spada, Massimiliano
    Morelli, Franco
    Prati, Giuseppe
    Nole, Franco
    Vignani, Francesca
    Cavo, Alessia
    Lipari, Helga
    Puglisi, Silvia
    Signori, Alessio
    Necchi, Andrea
    Banna, Giuseppe Luigi
    Fornarini, Giuseppe
    Buti, Sebastiano
    Rebuzzi, Sara Elena
    CLINICAL GENITOURINARY CANCER, 2025, 23 (01)
  • [8] Prognostic stratification by the Meet-URO score in a real-world elderly population of patients (pts) with metastatic renal cell carcinoma (mRCC) receiving cabozantinib: A subanalysis of the prospective ZEBRA study (Meet-URO 9).
    Damassi, Alessandra
    Cremante, Malvina
    Fornarini, Giuseppe
    Signori, Alessio
    Buti, Sebastiano
    Basso, Umberto
    Procopio, Giuseppe
    Maruzzo, Marco
    Soraru, Mariella
    Di Napoli, Marilena
    Fratino, Lucia
    Santini, Daniele
    Grillone, Francesco
    Ballestrin, Melissa
    Dionese, Michele
    Murianni, Veronica
    Catalano, Fabio
    Banna, Giuseppe Luigi L.
    Rescigno, Pasquale
    Rebuzzi, Sara Elena
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [9] Baseline and early change of systemic inflammation index (bSII and ΔSII) as prognostic factors in metastatic renal cell carcinoma (mRCC) patients treated with Nivolumab: Final results of the Meet-URO 15 (I-BIO-REC) study.
    Rebuzzi, Sara Elena
    Atzori, Francesco
    Di Napoli, Marilena
    Stellato, Marco
    Messina, Marco
    Chiellino, Silvia
    Vignani, Francesca
    Cavo, Alessia
    Parra, Hector J. Soto
    Roviello, Giandomenico
    Prati, Veronica
    Bimbatti, Davide
    De Giorgi, Ugo
    Bersanelli, Melissa
    Paolieri, Federico
    Zucali, Paolo Andrea
    Fantinel, Emanuela
    Procopio, Giuseppe
    Signori, Alessio
    Fornarini, Giuseppe
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [10] Validation of the Meet-URO score in patients with metastatic renal cell carcinoma receiving first-line nivolumab and ipilimumab in the Italian Expanded Access Program
    Rebuzzi, S. E.
    Signori, A.
    Buti, S.
    Banna, G. L.
    Murianni, V
    Damassi, A.
    Maruzzo, M.
    Giannarelli, D.
    Tortora, G.
    Galli, L.
    Rizzo, M.
    De Giorgi, U.
    Antonuzzo, L.
    Bracarda, S.
    Carteni, G.
    Atzori, F.
    Tamberi, S.
    Procopio, G.
    Fratino, L.
    Lo Re, G.
    Santoni, M.
    Baldessari, C.
    Astone, A.
    Calabro, F.
    Brunelli, M.
    Porta, C.
    Rescigno, P.
    Basso, U.
    Fornarini, G.
    ESMO OPEN, 2022, 7 (06)
1234